AbCellera Biologics, Inc. (ABCL)
4.155
+0.04
(+0.85%)
USD |
NASDAQ |
Jan 20, 16:00
4.15
0.00 (0.00%)
After-Hours: 16:58
AbCellera Biologics Market Cap: 1.244B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Achieve Life Sciences, Inc. | 292.25M |
| Oncolytics Biotech, Inc. | 106.52M |
| Aurinia Pharmaceuticals, Inc. | 1.951B |
| Edesa Biotech, Inc. | 10.26M |
| Lexaria Bioscience Corp. | 18.43M |
Market Cap Related Metrics
| PS Ratio | 35.02 |
| Price to Book Value | 1.290 |
| Price | 4.155 |
| Earnings Yield | -13.87% |